Clinical Trial Update: A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the CG8123 cancer vaccine with and without cyclophosphamide in advanced Non-Small Cell Lung Cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CG8123
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Cell Genesys | Conditions: Lung Cancer, Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED